Guangdong Hengrui Pharmaceutical Co., Ltd clinical trials

A subsidiary of Jiangsu HengRui Medicine Co., Ltd.

The registry lists 58 studies whose lead sponsor is Guangdong Hengrui Pharmaceutical Co., Ltd. 24 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 22, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 58. List all 58 → · All Jiangsu HengRui Medicine Co., Ltd. studies →

• A Phase II Study of SHR-2173 Injection in Patients With Myasthenia GravisRecruitingNCT07622342Phase 2

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd

• A Study of SHR-2173 in Participants With Systemic Lupus ErythematosusRecruitingNCT07299422Phase 2

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd

• A Study to Evaluate the Safety of SHR-7590 in Chinese Healthy Participants and in Patients With Moderate-to-severe Inflammatory Bowel DiseaseRecruitingNCT07758101Phase 1

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd

• A Randomized, Double-Blind, Dose-Escalation, Placebo-Controlled Study of SHR-1179 Injection in Participants With ObesityNot yet recruitingNCT07826364Phase 1

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd

• A Study of SHR-1819 Injection in Adolescents With Severe Atopic DermatitisRecruitingNCT07309055Phase 3

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd

• A Study on the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of SHR-7012 in Healthy AdultsRecruitingNCT07749651Phase 1

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd

• Phase II Clinical Trial of SHR-1139 Injection in Patients With PsoriasisRecruitingNCT07719530Phase 2

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd

• A Clinical Trial to Evaluate the Efficacy and Safety of HRS-9821 Inhalation Suspension in Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseRecruitingNCT07640451Phase 2

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd

• A Phase II Clinical Study to Evaluate the Efficacy and Safety of SHR-1139 Injection in Patients With Plaque PsoriasisNot yet recruitingNCT07758075Phase 2

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd

• A Phase I Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HRS-9821 Powder for Inhalation Administered as a Single Dose in Healthy Participants and Multiple Doses in Patients With COPDRecruitingNCT07567872Phase 1

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd

• A Study Comparing a Pre-filled Safety Syringe and an Autoinjector for SHR-1703 Injection in Healthy ParticipantsNot yet recruitingNCT07701239Phase 1

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd

• Phase I Study of SHR-2173 Injection in Patients With Primary Immune ThrombocytopeniaRecruitingNCT07206758Phase 1

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd

• A Study of SHR-2173 in Participants With Primary IgA NephropathyRecruitingNCT07354932Phase 2

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd

• Clinical Study of the Efficacy and Safety of SHR-1819 Injection in Adult Patients With Prurigo NodularisRecruitingNCT06554509Phase 2/3

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd

• A Study to Investigate the Efficacy and Safety of SHR-1905 in Patients With Moderate-to-severe Atopic DermatitisRecruitingNCT07211542Phase 2

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd

• A Study to Evaluate SHR-1139 Injection in Patients With Pyoderma GangrenosumNot yet recruitingNCT07444684Phase 2

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd

• Phase II Randomized, Open-label, Multicenter Clinical Study Evaluating the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of SHR-2173 Injection in Patients With Primary Membranous NephropathyRecruitingNCT07289763Phase 2

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd

• Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Trial to Evaluate the Efficacy and Safety of HRS-9813 in Subjects With Pulmonary FibrosisRecruitingNCT07192939Phase 2

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd

• A Study to Evaluate the Long-term Safety, Pharmacodynamics and Efficacy of SHR-1703 in Eosinophilic Asthma PatientsRecruitingNCT06441812Phase 2

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd

• A Study to Evaluate the Efficacy and Safety of SHR-1703 in Subjects With Eosinophilic Granulomatosis With Polyangiitis （EGPA）RecruitingNCT05979051Phase 2/3

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd

• A Phase II Clinical Study on the Efficacy and Safety of SHR-2173 Injection in the Treatment of Patients With Active Lupus NephritisRecruitingNCT07229742Phase 2

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd

• Efficacy and Safety of SHR-1905 Injection in Subjects With Chronic Rhinosinusitis With Nasal PolypsRecruitingNCT07132827Phase 3

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd

• A Trial of SHR-1905 in Subjects With Severe Uncontrolled AsthmaRecruitingNCT07098403Phase 3

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd

• Clinical Study on the Efficacy and Safety of SHR-4597 Inhalant in Adult Patients With AsthmaNot yet recruitingNCT06940700Phase 2

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd

• A Clinical Study Evaluating the Efficacy and Safety of SHR-1819 Injection in Patients With Seasonal Allergic RhinitisActive, not recruitingNCT07688772Phase 3

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd

• Study on the Drug Interactions of HRS-9813, Pirfenidone and Nintedanib in Healthy SubjectsCompletedNCT07229716Phase 1

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd

• A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics for a Single Dose of HRS-9821 Powder for Inhalation and Inhalation Suspension Administered in Healthy Subjects and Multiple Doses in Patients With COPD.CompletedNCT07116915Phase 1

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd

• Efficacy and Safety Study of SHR-1819 Injection in Adult Patients With Severe Atopic DermatitisCompletedNCT06468956Phase 3

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd

• A Clinical Study on the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of SHR-1819 Injection in Patients With Seasonal Allergic RhinitisCompletedNCT07091357Phase 2

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd

• A Study on the Bioavailability of SHR-1819 Injection Administered Subcutaneously Using Different Injection Devices in Healthy SubjectsCompletedNCT07264335Phase 1

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd

• A Multi-centered，Randomized，Double-blind，Placebo-controlled Study to Evaluate the Efficacy and Safety of SHR-1703 in Eosinophilic AsthmaActive, not recruitingNCT06653322Phase 3

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd

• Efficacy and Safety of SHR-1905 Injection in Patients With Chronic Rhinosinusitis With Nasal PolypsCompletedNCT05891483Phase 2

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd

• A Phase Ib/II Study to Investigate the Safety of SHR-1819 in Children and Adolescents With Moderate-to-severe Atopic DermatitisCompletedNCT06713499Phase 1/2

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd

• A Trial of HRS-9813 in Healthy SubjectsCompletedNCT06821464Phase 1

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd

• The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of SHR-3045 in Healthy SubjectsCompletedNCT07200596Phase 1

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd

• Safety and Tolerance of Increased Doses of SHR-2106 Injection in Healthy SubjectsCompletedNCT05948059Phase 1

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd

• A Phase Ⅰ Clinical Trial to Evaluate the Safety, Tolerance, Pharmacokinetics and Pharmacodynamics of SHR-3045 in Healthy SubjectsCompletedNCT06883695Phase 1

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd

• A Phase 2 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of SHR-1139 in Patients With Moderate-to-severe Active Ulcerative ColitisActive, not recruitingNCT07232576Phase 2

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd

• A Study of SHR-1819 in Patients With Moderate-to-severe Atopic DermatitisActive, not recruitingNCT07321951Phase 2

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd

• A Phase II Trial of SHR-3045 Injection in Patients With Rheumatoid ArthritisActive, not recruitingNCT07233655Phase 2

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd

• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SHR-4597 Inhalation in Healthy Subjects and Asthmatic PatientsCompletedNCT06385964Phase 1

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd

• A Phase I Study of SHR-4712 in Patients With Advanced Solid TumorsActive, not recruitingNCT06993116Phase 1

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd

• A Phase I Clinical Trial of Single Subcutaneous Injection or Intravenous Infusion of SHR-1139 Injection in Healthy Chinese Subjects and Multiple Subcutaneous Injections in Patients With Moderate-to-severe Plaque PsoriasisCompletedNCT07051538Phase 1

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd

• A Study to Assess the Efficacy and Tolerance of HRS-2261 in Subjects With Refractory Chronic CoughCompletedNCT05733533Phase 2

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd

• Pharmacokinetics, Pharmacodynamics, Safety, and Preliminary Efficacy of Subcutaneous Injection of SHR-1905 in Adolescent Asthmatic Subjects - an Open-label, Single-dose Phase II Clinical StudyCompletedNCT06786455Phase 2

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd

• A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Subcutaneous Injections of SHR-2173 in Patients With Systemic Lupus ErythematosusCompletedNCT06955598Phase 1

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd

• Study on Single and Multiple Atomization Inhalation of HRS-9821 Suspension for Inhalation in Healthy Subjects and COPD PatientsCompletedNCT05622864Phase 1

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd

• A Trial Comparing SHR-1139 Injection With Placebo in Patients With Moderate-to-severe Plaque PsoriasisActive, not recruitingNCT06875934Phase 2

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd

• A Trial of HRS-9813 Capsule and Tablet in Healthy SubjectsCompletedNCT06939504Phase 1

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd

• A Phase I Study of SHR -2001 in Healthy SubjectsCompletedNCT05942612Phase 1

  Sponsor listed in the registry: Guangdong Hengrui Pharmaceutical Co., Ltd